Search hospitals > Tennessee > Nashville
Sarah Cannon Cancer Center
Claim this profileNashville, Tennessee 37203
Global Leader in Tumors
Global Leader in Solid Tumors
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
219 reported clinical trials
14 medical researchers
Summary
Sarah Cannon Cancer Center is a medical facility located in Nashville, Tennessee. This center is recognized for care of Tumors, Solid Tumors, Non-Small Cell Lung Cancer, Breast Cancer, Cancer and other specialties. Sarah Cannon Cancer Center is involved with conducting 219 clinical trials across 159 conditions. There are 14 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and Gerald Falchook, MD.Area of expertise
1Tumors
Global LeaderStage IV
Stage III
FGFR3 positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Melissa Johnson, MDSarah Cannon Research Institute5 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Tumors
61 reported clinical trials
88 drugs studied
Erika P HamiltonSarah Cannon Research Institute4 years of reported clinical research
Expert in Breast Cancer
Expert in Ovarian Cancer
53 reported clinical trials
76 drugs studied
Meredith A McKeanSarah Cannon Research Institute1 year of reported clinical research
Expert in Solid Tumors
Expert in Tumors
34 reported clinical trials
66 drugs studied
Gerald Falchook, MDSarah Cannon Research Institute at HealthONE5 years of reported clinical research
Expert in Tumors
Expert in Solid Tumors
38 reported clinical trials
59 drugs studied
Clinical Trials running at Sarah Cannon Cancer Center
Solid Tumors
Breast Cancer
Pancreatic Cancer
Tumors
Prostate Cancer
Cancer
Non-Small Cell Lung Cancer
Kidney Cancer
Renal Cell Carcinoma
Melanoma
REGN7075 + Cemiplimab
for Advanced Cancer
This trial is testing a new drug called REGN7075, alone or with other treatments, on patients with advanced solid tumors. The goal is to see if it can stop tumor growth and shrink the tumors.
Recruiting1 award Phase 1 & 28 criteria
AMG 193 + IDE397
for Solid Cancers
This trial tests the safety and best dose of two drugs, AMG 193 and IDE397, in adults with advanced cancers missing the MTAP gene, especially lung cancer. The goal is to see if this combination can effectively fight these cancers.
Recruiting1 award Phase 1 & 28 criteria
IMM-6-415
for Solid Tumors
This is a FIH, ascending dose study to characterize the safety, tolerability, optimal dose and preliminary anti-tumor activity of IMM-6-415 in participants with advanced or metastatic solid tumors harboring RAS or RAF oncogenic mutations.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sarah Cannon Cancer Center?
Sarah Cannon Cancer Center is a medical facility located in Nashville, Tennessee. This center is recognized for care of Tumors, Solid Tumors, Non-Small Cell Lung Cancer, Breast Cancer, Cancer and other specialties. Sarah Cannon Cancer Center is involved with conducting 219 clinical trials across 159 conditions. There are 14 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and Gerald Falchook, MD.